Cargando…
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
Tetraspanin 8 (TSPAN8) is a member of the tetraspanin superfamily that forms TSPAN8-mediated protein complexes by interacting with themselves and other various cellular signaling molecules. These protein complexes help build tetraspanin-enriched microdomains (TEMs) that efficiently mediate intracell...
Autores principales: | Heo, Kyun, Lee, Sukmook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175299/ https://www.ncbi.nlm.nih.gov/pubmed/32138170 http://dx.doi.org/10.3390/biom10030388 |
Ejemplares similares
-
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
por: Kim, Ji Woong, et al.
Publicado: (2021) -
Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029
por: Bonnet, Mathilde, et al.
Publicado: (2019) -
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021) -
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
por: Kong, Deok-Hoon, et al.
Publicado: (2017) -
Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)